［1］Goodell MA,Brose K,Paradis G,et al.Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo［J］.J Exp Med,1996,183(4):1797-1806.
［2］Dai Y,Liu S,Zhang WQ,et al.YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells［J］.Oncotarget,2017,8(3):4096-4109.
［3］Prasanphanich AF,White DE,Gran MA,et al.Kinetic modeling of ABCG2 transporter heterogeneity:A quantitative,single-cell analysis of the side population assay［J］.PLoS Computational Biology,2016,12(11):e1005188.
［4］Wei Z,Liu Y,Wang Y,et al.Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation,invasion,and drug resistance of ovarian cancer［J］.Medical Oncology,2016,33(11):126.
［5］Jiang Y,Gao H,Liu M,et al.Sorting and biological characteristics analysis for side population cells in human primary hepatocellular carcinoma［J］.American Journal of Cancer Research,2016,6(9):1890-1905.
［6］Gu H,Wu XY,Fan RT,et al.Side population cells from long-term passage non-small cell lung cancer cells display loss of cancer stem cell-like properties and chemoradioresistance［J］.Oncology Letters,2016,12(4):2886-2893.
［7］Liu H,Shi B,Yan Y,et al.CXCR4 promotes growth and sphere formation of hypoxic breast cancer side 7 population cells via activation of c-Jun/ABCG2 pathway［J］.Oncology Research,2016,7:21.
［8］Wei Z,Lv S,Wang Y,et al.Biological characteristics of side population cells in a self-established human ovarian cancer cell line［J］.Oncol Lett,2016,12(1):41-48.
［9］Xue T,Lu ZN.Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population［J］.Genetics and Molecular Research,2016,15(4):32.
［10］Li W,Zhang H,Assaraf YG,et al.Overcoming ABC transporter-mediated multidrug resistance:Molecular mechanisms and novel therapeutic drug strategies.Drug resistance updates:reviews and commentaries in antimicrobial and anticancer chemotherapy［J］.Cancer,2016,27:14-29.
［11］El-Awady R,Saleh E,Hashim A,et al.The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy［J］.Frontiers in pharmacology,2016,7:535.
［12］Lage H.Gene therapeutic approaches to overcome ABCB1-mediated drug resistance［J］.Recent Results in Cancer Research,2016,209:87-94.
［13］Varatharajan S,Abraham A,Karathedath S,et al.ATP-binding casette transporter expression in acute myeloid leukemia:association with in vitro cytotoxicity and prognostic markers［J］.Pharmacogenomics,2017,18(3):235-244.
［14］Balaji SA,Udupa N,Chamallamudi MR,et al.Role of the drug transporter ABCC3 in breast cancer chemoresistance［J］.PloS One,2016,11(5):e0155013.
［15］Stacy AE,Jansson PJ,Richardson DR.Molecular pharmacology of ABCG2 and its role in chemoresistance［J］.Molecular Pharmacology,2013,84(5):655-669.
［16］Fischer B,Frei C,Moura U,et al.Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy［J］.Lung Cancer,2012,78(1):23-29.
［17］Chang FW,Fan HC,Liu JM,et al.Estrogen enhances the expression of the multidrug transporter gene ABCG2-increasing drug resistance of breast cancer cells through estrogen receptors［J］.International Journal of Molecular Sciences,2017,18(1):E163.
［18］Spitzwieser M,Pirker C,Koblmuller B,et al.Promoter methylation patterns of ABCB1,ABCC1 and ABCG2 in human cancer cell lines,multidrug-resistant cell models and tumor,tumor-adjacent and tumor-distant tissues from breast cancer patients［J］.Oncotarget,2016,7(45):73347-73369.